Literature DB >> 31746971

Absence of Autoantibodies Against Neuronal Surface Antigens in Sera of Patients With Psychotic Disorders.

Carolin Hoffmann1, Shenghua Zong1, Marina Mané-Damas1, Peter C Molenaar1, Mario Losen1, Maarten J Titulaer2, Pilar Martinez-Martinez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31746971      PMCID： PMC6902152          DOI： 10.1001/jamapsychiatry.2019.3679

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  6 in total

1.  Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies.

Authors:  Lot D de Witte; Carolin Hoffmann; Hans C van Mierlo; Maarten J Titulaer; René S Kahn; Pilar Martinez-Martinez
Journal:  JAMA Psychiatry       Date:  2015-07       Impact factor: 21.596

2.  Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study.

Authors:  Belinda R Lennox; Emma C Palmer-Cooper; Thomas Pollak; Jane Hainsworth; Jacqui Marks; Leslie Jacobson; Bethan Lang; Hannah Fox; Berne Ferry; Linda Scoriels; Hannah Crowley; Peter B Jones; Paul J Harrison; Angela Vincent
Journal:  Lancet Psychiatry       Date:  2016-12-08       Impact factor: 27.083

3.  Autoimmune Encephalitis in Postpartum Psychosis.

Authors:  Veerle Bergink; Thaís Armangue; Maarten J Titulaer; Sander Markx; Josep Dalmau; Steven A Kushner
Journal:  Am J Psychiatry       Date:  2015-07-17       Impact factor: 18.112

Review 4.  An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.

Authors:  Josep Dalmau; Thais Armangué; Jesús Planagumà; Marija Radosevic; Francesco Mannara; Frank Leypoldt; Christian Geis; Eric Lancaster; Maarten J Titulaer; Myrna R Rosenfeld; Francesc Graus
Journal:  Lancet Neurol       Date:  2019-07-17       Impact factor: 44.182

5.  Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

Authors:  Matthew S Kayser; Maarten J Titulaer; Núria Gresa-Arribas; Josep Dalmau
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

6.  Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients.

Authors:  Dominique Endres; Evgeniy Perlov; Annette Baumgartner; Tilman Hottenrott; Rick Dersch; Oliver Stich; Ludger Tebartz van Elst
Journal:  Front Hum Neurosci       Date:  2015-09-10       Impact factor: 3.169
  6 in total
  5 in total

Review 1.  Autoantibody Encephalitis: Presentation, Diagnosis, and Management.

Authors:  Eric Lancaster
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

2.  Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety.

Authors:  Shenghua Zong; Carolin Correia-Hoffmann; Marina Mané-Damas; Nils Kappelmann; Peter C Molenaar; Gerard van Grootheest; Brenda W J H Penninx; Rob P W Rouhl; Mario Losen; Pilar Martinez-Martinez
Journal:  Transl Psychiatry       Date:  2020-11-23       Impact factor: 6.222

3.  Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis.

Authors:  Fredrik Piehl; Sarosh R Irani; Jakob Theorell; Melanie Ramberger; Ruby Harrison; Victor Mgbachi; Leslie Jacobson; Patrick Waters; Sophie Erhardt; Carl M Sellgren; Simon Cervenka
Journal:  Transl Psychiatry       Date:  2021-11-05       Impact factor: 6.222

4.  Unidentified Neuronal Surface IgG Autoantibodies in a Case of Hashimoto's Encephalopathy.

Authors:  Marina Mané-Damas; Anita Vinke; Carolin Hoffmann; Shenghua Zong; Mario Losen; Peter C Molenaar; Jan Damoiseaux; Suzanne Koudijs; Rob P W Rouhl; Pilar Martinez-Martinez
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 5.  Cognitive impact of neuronal antibodies: encephalitis and beyond.

Authors:  L L Gibson; A McKeever; E Coutinho; C Finke; T A Pollak
Journal:  Transl Psychiatry       Date:  2020-09-01       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.